Baidu
map

2021年11月21日简报:钟南山鼓励更多老人接种新冠疫苗,国内新冠疫苗人群覆盖率分别达到了86.9%;日本和以色列均计划为5-11岁儿童接种新冠疫苗

2021-11-21 MedSci整理 MedSci整理

截至北京时间2021年11月21日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿5739万例,新增467,308例,达到257,393,

截至北京时间2021年11月21日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过2亿5739万例,新增467,308例,达到257,393,136例。累计死亡病例516.2万例,达到5,162,798例。新增死亡为5,423例。康复为232,332,589例,重症和危重症病人达到79,363例;全球新冠确诊病例超过100万例的国家达36个,112个国家病例超10万例。昨日报道:2021年11月20日简报:国内本轮疫情基本得到控制;新冠病毒在美国白尾鹿间爆炸式传播,最早可能是2019年;盖茨预测全球疫情明年夏天或迎拐点

多国疫情急剧反弹,欧洲再次成全球新冠疫情“震中”

欧洲近期再次成为全球新冠疫情“震中”。多国政府和民众担忧,仅靠加快疫苗接种进度无法遏制疫情恶化。因此包括奥地利、比利时、德国在内的多国除了继续推进疫苗接种,也陆续重启了更为严格的防疫措施。

奥地利单日新增确诊病例超1.5万例

奥地利卫生部网站19日公布的数据显示,该国过去24小时新增新冠确诊病例15809例,创下疫情暴发以来单日新增最高纪录;累计确诊病例超过100万例;新增死亡病例48例,累计死亡11951例。

奥地利政府19日宣布,从22日起对全国所有居民实施为期10天的“封禁”措施,这将成为欧盟首个再次全国范围“封城”的国家。之后奥地利会根据疫情评估形势可能再延长10天,最迟20天后回到仅对未接种疫苗者实施“封禁”的状态。这是自疫情暴发以来奥地利第四次宣布全国性“封禁”。

奥地利明年将强制人们接种疫苗

奥地利防疫措施收紧,奥地利总理沙伦贝格说,“封城”期间,学生在家上课,餐馆关闭,文化活动取消。此外,据奥地利广播公司报道,从明年2月1日起,奥地利将强制人们接种疫苗。该国也将成为欧盟第一个实行强制性疫苗接种的国家。奥地利大约三分之二人口完成新冠疫苗全程接种。这一比例在西欧国家中较低。奥地利在本周一15日开始对未接种疫苗者“封城”,此举收效尚不明显。

德国疫情正在急剧恶化

根据德国联邦疾控机构罗伯特·科赫研究所发布的最新数据,截至当地时间今天(11月20日)凌晨,德国累计新冠肺炎确诊病例升至5312215例,较前一日新增63924例。这也是德国单日新增确诊病例第二次超过6万例。另外,德国的累计死亡病例升至98987例,较前一日新增248例。当地时间19日,德国看守内阁卫生部长施潘和德国疾控机构罗伯特·科赫研究所所长威勒在柏林共同发出警告称,德国目前的疫情形势正在急剧恶化。

施潘表示,德国的疫情形势正在进一步恶化,感染的势头并没有中断,7天内每10万人发病率在4周内增加了5倍,医疗资源的形势也十分紧张。因此需要全国共同努力,采取坚决的行动来打破这种势头。施潘认为,仅依靠现有的防疫措施和疫苗接种进度无法在短期内打破感染潮。

我国76.3%人群完成新冠疫苗全程接种

吴良有介绍,这次疫情能在较短时间内得到控制,得益于我国较高的新冠病毒疫苗的接种率

截止到11月19日,我国疫苗接种已经覆盖12.25亿人,完成全程接种10.76亿人,人群覆盖率分别达到了86.9%和76.3%,加强免疫接种6573万人,为阻断新冠病毒传播、防止重症的发生等起到重要作用。

钟南山:鼓励70岁至80岁的老年人群体打新冠疫苗

在三届中国老年健康国际论坛的开幕式上,共和国勋章获得者钟南山先生还发表了致辞,他表示:现在的疫情形势依旧很严峻,大家一定要做好防范。并且现在70岁至80岁年龄段的老年人新冠疫苗接种率较低,我建议这个年龄阶段的老年群体要及时地去进行新冠疫苗的预防接种。

钟南山先生说得很对,虽然现在很多年轻人都已经完成了新冠疫苗的预防接种,但还有一些老人家压根就不知道有这回事。所以,我们在保护自己身体的同时,也要去多关心家里老人的疫苗接种情况。

日本计划明年2月为5至11岁儿童接种新冠疫苗

据《朝日新闻》报道,日本厚生劳动表示,最快明年2月份起为5至11岁的儿童接种新冠疫苗,要求地方政府做好准备。

本月10日美国辉瑞公司向日本厚劳省提交了儿童疫苗的认可申请,现阶段尚未通过。据报道,5至11岁儿童适用的辉瑞疫苗中,有效成分含量为12岁以上适用疫苗的三分之一。

目前日本疫情已得到完全控制

以色列批准为 5 至 11 岁儿童接种新冠疫苗

以色列卫生部 14 日发表声明说,卫生部总干事纳赫曼 · 阿什已批准为该国 5 至 11 岁儿童接种新冠疫苗,该年龄段的疫苗接种开始时间 " 将在未来几天内确定 "。

声明说,美国辉瑞公司数据显示,辉瑞疫苗预防 5 至 11 岁儿童感染新冠病毒的有效率接近 91%。以卫生部疫苗接种咨询委员会的大部分成员认为该年龄段儿童 " 接种(新冠)疫苗的收益大于风险 "。

国家新冠项目负责人萨尔曼 · 扎尔卡 14 日表示,用于儿童接种的新冠疫苗将在一周内运抵以色列。报道还说,5 至 11 岁儿童接种新冠疫苗的剂量将是 12 岁及以上年龄段人群适用剂量的三分之一。

以色列虽然放宽入境,但是疫情完全得到控制

数据显示,截至 14 日,以色列累计确诊新冠病例约 134 万例,累计死亡 8140 例。近来,以色列新冠疫情逐渐缓和。该国政府已从 11 月 1 日起有条件允许外国游客入境,11 月 9 日又宣布将进一步放宽国内疫情防控措施。

以色列自 2020 年 12 月开始新冠疫苗接种工作,目前为 12 岁及以上年龄段人群接种,主要采用的是辉瑞疫苗。数据显示,截至 14 日,该国 930 万人口中约 626 万人已至少接种一剂疫苗,约 575 万人完成两剂疫苗接种,约 402 万人接种了疫苗加强针。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2038125, encodeId=3fd02038125ab, content=<a href='/topic/show?id=d26690569a5' target=_blank style='color:#2F92EE;'>#覆盖率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90569, encryptionId=d26690569a5, topicName=覆盖率)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Apr 19 09:08:55 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073280, encodeId=b64f10e328043, content=祝愿全民健健康康,, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er8t83BVhnMmRVw8ht6ZVk18RORicCI7Smjib7cpQ8g0AQ2OwjNhwyhibXOluq4Ok3DY5KDCibloRaMhQ/132, createdBy=27722327936, createdName=点点嗨, createdTime=Tue Nov 23 20:21:12 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294649, encodeId=f7c9129464900, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Mon Nov 22 22:08:55 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072454, encodeId=098310e245447, content=期待进一步接种疫苗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96425723286, createdName=ms5000000353966274, createdTime=Sun Nov 21 10:17:40 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072450, encodeId=afc610e2450b0, content=期待新疫苗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sun Nov 21 10:08:40 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072418, encodeId=104510e241877, content=全民接种。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Sun Nov 21 08:16:56 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2038125, encodeId=3fd02038125ab, content=<a href='/topic/show?id=d26690569a5' target=_blank style='color:#2F92EE;'>#覆盖率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90569, encryptionId=d26690569a5, topicName=覆盖率)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Apr 19 09:08:55 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073280, encodeId=b64f10e328043, content=祝愿全民健健康康,, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er8t83BVhnMmRVw8ht6ZVk18RORicCI7Smjib7cpQ8g0AQ2OwjNhwyhibXOluq4Ok3DY5KDCibloRaMhQ/132, createdBy=27722327936, createdName=点点嗨, createdTime=Tue Nov 23 20:21:12 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294649, encodeId=f7c9129464900, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Mon Nov 22 22:08:55 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072454, encodeId=098310e245447, content=期待进一步接种疫苗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96425723286, createdName=ms5000000353966274, createdTime=Sun Nov 21 10:17:40 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072450, encodeId=afc610e2450b0, content=期待新疫苗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sun Nov 21 10:08:40 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072418, encodeId=104510e241877, content=全民接种。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Sun Nov 21 08:16:56 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2021-11-23 点点嗨

    祝愿全民健健康康,

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2038125, encodeId=3fd02038125ab, content=<a href='/topic/show?id=d26690569a5' target=_blank style='color:#2F92EE;'>#覆盖率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90569, encryptionId=d26690569a5, topicName=覆盖率)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Apr 19 09:08:55 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073280, encodeId=b64f10e328043, content=祝愿全民健健康康,, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er8t83BVhnMmRVw8ht6ZVk18RORicCI7Smjib7cpQ8g0AQ2OwjNhwyhibXOluq4Ok3DY5KDCibloRaMhQ/132, createdBy=27722327936, createdName=点点嗨, createdTime=Tue Nov 23 20:21:12 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294649, encodeId=f7c9129464900, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Mon Nov 22 22:08:55 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072454, encodeId=098310e245447, content=期待进一步接种疫苗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96425723286, createdName=ms5000000353966274, createdTime=Sun Nov 21 10:17:40 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072450, encodeId=afc610e2450b0, content=期待新疫苗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sun Nov 21 10:08:40 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072418, encodeId=104510e241877, content=全民接种。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Sun Nov 21 08:16:56 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2038125, encodeId=3fd02038125ab, content=<a href='/topic/show?id=d26690569a5' target=_blank style='color:#2F92EE;'>#覆盖率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90569, encryptionId=d26690569a5, topicName=覆盖率)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Apr 19 09:08:55 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073280, encodeId=b64f10e328043, content=祝愿全民健健康康,, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er8t83BVhnMmRVw8ht6ZVk18RORicCI7Smjib7cpQ8g0AQ2OwjNhwyhibXOluq4Ok3DY5KDCibloRaMhQ/132, createdBy=27722327936, createdName=点点嗨, createdTime=Tue Nov 23 20:21:12 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294649, encodeId=f7c9129464900, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Mon Nov 22 22:08:55 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072454, encodeId=098310e245447, content=期待进一步接种疫苗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96425723286, createdName=ms5000000353966274, createdTime=Sun Nov 21 10:17:40 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072450, encodeId=afc610e2450b0, content=期待新疫苗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sun Nov 21 10:08:40 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072418, encodeId=104510e241877, content=全民接种。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Sun Nov 21 08:16:56 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2021-11-21 ms5000000353966274

    期待进一步接种疫苗

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2038125, encodeId=3fd02038125ab, content=<a href='/topic/show?id=d26690569a5' target=_blank style='color:#2F92EE;'>#覆盖率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90569, encryptionId=d26690569a5, topicName=覆盖率)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Apr 19 09:08:55 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073280, encodeId=b64f10e328043, content=祝愿全民健健康康,, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er8t83BVhnMmRVw8ht6ZVk18RORicCI7Smjib7cpQ8g0AQ2OwjNhwyhibXOluq4Ok3DY5KDCibloRaMhQ/132, createdBy=27722327936, createdName=点点嗨, createdTime=Tue Nov 23 20:21:12 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294649, encodeId=f7c9129464900, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Mon Nov 22 22:08:55 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072454, encodeId=098310e245447, content=期待进一步接种疫苗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96425723286, createdName=ms5000000353966274, createdTime=Sun Nov 21 10:17:40 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072450, encodeId=afc610e2450b0, content=期待新疫苗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sun Nov 21 10:08:40 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072418, encodeId=104510e241877, content=全民接种。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Sun Nov 21 08:16:56 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2021-11-21 weigq

    期待新疫苗。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2038125, encodeId=3fd02038125ab, content=<a href='/topic/show?id=d26690569a5' target=_blank style='color:#2F92EE;'>#覆盖率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90569, encryptionId=d26690569a5, topicName=覆盖率)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Apr 19 09:08:55 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073280, encodeId=b64f10e328043, content=祝愿全民健健康康,, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er8t83BVhnMmRVw8ht6ZVk18RORicCI7Smjib7cpQ8g0AQ2OwjNhwyhibXOluq4Ok3DY5KDCibloRaMhQ/132, createdBy=27722327936, createdName=点点嗨, createdTime=Tue Nov 23 20:21:12 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294649, encodeId=f7c9129464900, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Mon Nov 22 22:08:55 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072454, encodeId=098310e245447, content=期待进一步接种疫苗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96425723286, createdName=ms5000000353966274, createdTime=Sun Nov 21 10:17:40 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072450, encodeId=afc610e2450b0, content=期待新疫苗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sun Nov 21 10:08:40 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072418, encodeId=104510e241877, content=全民接种。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Sun Nov 21 08:16:56 CST 2021, time=2021-11-21, status=1, ipAttribution=)]
    2021-11-21 moyanju2796

    全民接种。

    0

相关资讯

2021年11月14日简报:张文宏认为有必要继续实施强大的公共卫生政策;国内3至11岁人群超8439万人接种新冠疫苗,18岁以上学生新冠疫苗接种率超95%;

截至北京时间2021年11月14日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿5363万例,新增410,690例,达到253,639,

Lancet Respir Med:苏格兰25700万人接种新冠疫苗后的住院和死亡风险

老年人、合并症较多,接种疫苗前几周住院、高危职业、养老院居民、贫困、男性和既往吸烟者因COVID-19住院和死亡风险较高。

2021年11月15日简报:FDA前局长:全美明年1月将结束疫情;美国三分之一的老年人接种了新冠疫苗加强针;美国新冠疫苗接种率更高的佛蒙特州确诊病例激增

截至北京时间2021年11月15日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿5400万例,新增337,744例,达到254,005,

2021年11月18日简报:多国新增病例创新高,但全球死亡人数平稳;多国死亡人数中位年龄为80岁左右;我国全力推进老年人新冠疫苗应接尽接

截至北京时间2021年11月18日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿5563万例,新增552,717例,达到255,636,

2021年11月19日简报:国内31省市累计接种新冠疫苗超24.02亿剂次;国内小分子3CL蛋白酶抑制剂SIM0417也将进入临床试验阶段

截至北京时间2021年11月19日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿5629万例,新增586,147例,达到256,294,

NEJM: BNT162b2疫苗在5-11岁儿童中的应用评价

在5~11岁儿童中,BNT162b2疫苗具有较好的安全性。

Baidu
map
Baidu
map
Baidu
map